Will a personalized mRNA cancer vaccine from any company receive marketing authorization in the EU by December 31, 2026?
Resolves: YES if any personalized mRNA cancer vaccine receives marketing authorization from the European Medicines Agency (EMA) on or before December 31, 2026. NO otherwise.
Will a personalized mRNA cancer vaccine from any company receive mark…
Market overview
Moderna and Merck's success suggests a breakthrough in personalized mRNA cancer vaccines, potentially paving the way for other companies or for their own product to gain approval in major markets like the EU. Regulatory processes are stringent but the promise of the technology is high.
World prediction market
- Implied probability (Yes)
- 55%
- Closes
- 2026-12-31
About this prediction
How this resolves
YES if any personalized mRNA cancer vaccine receives marketing authorization from the European Medicines Agency (EMA) on or before December 31, 2026. NO otherwise.
Source: user-generated
More World markets
- Will Australian Open dominate headlines in the next 12-18 months? — 30% Yes
- Will a documentary or major film about the conviction of Duane 'Keffe D' Davis be released by the end of 2026? — 70% Yes
- Will any major national news outlet (e.g., CNN, Fox News, NYT, Washington Post) publish a follow-up article on the California couple's legal proceedings by September 29, 2027? — 70% Yes
- Will the name 'Lake America' be officially adopted for Lake Ontario by any governing body by January 20, 2029? — 2% Yes
- Will the 'Bullet-Riddled Car' exhibit featuring Hind Rajab's car remain on public display in Berlin for at least 30 consecutive days? — 70% Yes
- Will Converse announce a new partnership with a prominent social justice or anti-racism organization by December 31, 2027? — 60% Yes
- Will a unified, internationally recognized government be formed in Libya by June 30, 2026? — 30% Yes
- Will the Aoba Castle site see an increase of at least 10% in annual tourist visitors in 2026 compared to 2023 levels? — 45% Yes